HOME >> BIOLOGY >> NEWS
NIH funds new AIDS drug discovery research with $4.6 million

NEW BRUNSWICK/PISCATAWAY, N.J. The National Institute of General Medical Sciences (NIGMS), a unit of the National Institutes of Health (NIH), has awarded a grant of more than $4.6 million to fund four interrelated research projects centered at Rutgers, The State University of New Jersey.

The overall program will use a combination of structural, chemical and biological tools to further the development of new and more effective drugs to combat AIDS. The five-year grant is being provided under the NIGMS initiative, Structural Biology of AIDS-Related Proteins.

Eddy Arnold, a resident faculty member of the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers' Piscataway campus and a professor in Rutgers' department of chemistry and chemical biology, will serve as program director for the four projects. CABM is a research institute jointly administered by the University of Medicine and Dentistry of New Jersey (UMDNJ) and Rutgers.

"This major award enables Professor Arnold and his colleagues to continue their powerful work to develop effective treatments for this dreadful disease that threatens the well-being of millions of people worldwide," said Joseph J. Seneca, Rutgers' university vice president for academic affairs. "Rutgers is proud to have the work of its scientists recognized by this highly competitive award and to contribute to the improvement of public health through basic research."

Concurrent with his role as program director, Arnold will also function as principal investigator on one of the four projects, assisted by co-principal investigator Stefanos Sarafianos, an associate research professor at CABM. The other projects are led by Roger A. Jones, professor of chemistry and chemical biology at Rutgers and chair of the department; Stephen H. Hughes, a laboratory and section chief in the NIH National Cancer Institute's HIV Drug Resistance Program; and Michael A. Parniak, a professor of medicine in the Division
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
12-Nov-2002


Page: 1 2 3 4

Related biology news :

1. NIGMS funds Center for Quantitative Biology
2. $5 million grant funds partnership, studies of minority-based issues in reproductive health
3. NIH funds new Boston College-Boston University study of B-1a cell associated with leukemia
4. NSF funds summer research program abroad for undergraduates at UC San Diego
5. Research to create lung-cancer blood tests receives $3.4M in Pennsylvania tobacco settlement funds
6. The DFG funds a new research vessel
7. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
8. Grant funds research to develop tissue-engineered solutions for heart disease
9. Stuart research funds generating dividends for veterinary medicine
10. Grant funds research to develop microbicide barrier to HIV
11. $24-million grant funds local researchers to create encyclopedia of the innate immune system

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... ... November 13, 2019 , ... NDA Partners Chairman ... a regulatory affairs and program management executive with more than 33 years of ... joined the firm as an Expert Consultant. , Robert Peterson has extensive ...
(Date:11/14/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... clinical trial for stem cell treatment of knee osteoarthritis . The first treatment came ... of VetStem Biopharma. , In July of 2019, PSC received FDA approval ...
(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... manufacturing of orthopedic medical devices, today announced the creation of a Global Regulatory ... in the Medical Device industry is that the regulatory element to any Medtech ...
Breaking Biology News(10 mins):
(Date:11/12/2019)... ... November 12, 2019 , ... ... they have been selected by Lantern Pharma to provided preclinical screening and drug ... millions of data points using panels of unique and genetically edited cell lines ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... biopharmaceutical R&D, today announced that Immatics Biotechnologies , a clinical-stage biopharmaceutical ... to streamline their R&D operations related to the discovery and development ...
(Date:11/12/2019)... FALLS, Wis. (PRWEB) , ... November 12, 2019 ... ... label food ingredient solutions for the food and beverage industry launched a new ... to improve the digital experience. Now, the website offers global visitors updated ingredient ...
(Date:11/12/2019)... ... November 12, 2019 , ... Bode ... Director of Forensic Genealogy, Melinde Lutz Byrne, to the organization. Byrne’s team will ... provide investigative leads to law enforcement through proven genealogy and DNA analysis methods. ...
Breaking Biology Technology:
Cached News: